移植时胚胎质量是否影响产科结局和胎盘发现?
该回顾性队列研究纳入2009至2017年间641例单囊胚移植后活产的IVF妊娠,比较低质量囊胚移植组与优质囊胚对照组。调整混杂因素后,低质量胚胎与低置胎盘及多种胎盘病变风险升高相关,但未增加其他不良产科结局。
要点
- 低质量囊胚移植与低置胎盘风险升高相关(aOR 2.35,95%CI 1.02-5.41,P=0.04)。
- 低质量胚胎组原因不明绒毛炎、远端绒毛发育不良等胎盘病变风险升高。
- 上述胎盘病变未伴随额外不良产科结局,作者认为结果对临床和患者有安抚作用。
核心结论
- 低质量胚胎移植与低置胎盘及多种胎盘病变风险升高相关,但未伴随额外不良产科结局,作者认为该结果对需移植低质量胚胎的临床医生和患者有安抚作用。
- 作者认为本研究所见胎盘病变提示对低质量胚胎植入的免疫反应发生改变,但需在更大队列中 reaffirmation(原文表述)。
研究设计与样本
- 回顾性队列研究,纳入2009至2017年间641例IVF妊娠分娩。
- 研究对象为大学附属三级医院单囊胚移植后活产单胎,排除卵母细胞受者和IVM周期。
- 比较低质量囊胚移植组(132例)与优质囊胚对照组(509例)。
- 研究期间所有复杂及非复杂妊娠的胎盘均送病理检查。
主要发现
- 低质量组卵巢储备减退诊断比例高于对照组(14.3% vs 5.5%,P<0.001),且更多为冻融胚胎移植。
- 调整混杂因素后,低质量胚胎与低置胎盘风险升高相关(aOR 2.35,95%CI 1.02-5.41,P=0.04)。
- 低质量胚胎与原因不明绒毛炎风险升高相关(aOR 2.97,95%CI 1.17-6.66,P=0.02)。
- 低质量胚胎与远端绒毛发育不良风险升高相关(aOR 3.78,95%CI 1.20-11.38,P=0.02)。
- 低质量胚胎与绒毛间血栓风险升高相关(aOR 2.41,95%CI 1.39-4.16,P=0.001)。
关键数值与推荐
- 胎盘病变按阿姆斯特丹胎盘工作小组共识分类,包括解剖、炎症、血管灌注不良和绒毛成熟病变。
- 调整的混杂因素为卵巢储备减退、新鲜与冻融移植及新生儿性别(依据单变量分析指示)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究受回顾性设计限制。
- 研究期间使用了两种分级系统。
- 样本量有限,不足以检测较罕见结局的差异。
- 作者指出上述发现需在更大队列中 reaffirmation(原文表述)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do obstetric outcomes and placental findings in pregnancies conceived with IVF vary according to embryo quality? SUMMARY ANSWER: Pregnancies following the transfer of lower-quality embryos were associated with a higher rate of low-lying placentas and several adverse placental lesions. WHAT IS KNOWN ALREADY: A few studies have shown reduced pregnancy and live births rates with poor-quality embryo transfer, yet with comparable obstetric outcomes. None of these studies included placental analysis. STUDY DESIGN, SIZE, DURATION: A retrospective cohort study of 641 deliveries of IVF attained pregnancies between 2009 and 2017 was carried out. PARTICIPANTS/MATERIALS, SETTING, METHODS: Live singleton births after IVF with a single blastocyst transfer at a university-affiliated tertiary hospital were included. Excluded were cycles of oocyte recipients and IVM. We compared pregnancies following the transfer of a poor-quality blastocyst (poor-quality group) or a good-quality blastocyst (controls, good-quality group). During the study period, all placentas from complicated and uncomplicated pregnancies were sent to pathology. Primary outcomes were placental findings, including anatomic, inflammatory, vascular malperfusion, and villous maturation lesions, categorized according to the Amsterdam Placental Workshop Group Consensus. Secondary outcomes included obstetric and perinatal outcomes, adjusted for diminished ovarian reserve, fresh versus frozen transfer, and neonatal gender (as indicated by univariable analysis). MAIN RESULTS AND THE ROLE OF CHANCE: A total of 132 deliveries in the poor-quality group were compared to 509 controls. A diagnosis of diminished ovarian reserve was more common in the poor-quality group than in the control group (14.3% versus 5.5%, respectively, P < 0.001) and more pregnancies in the poor-quality group were following frozen embryo transfer. After adjustment for confounders, poor-quality embryos were associated with a higher rate of low-lying placentas [adjusted odds ratio (aOR) 2.35, 95% CI 1.02-5.41, P = 0.04] and placentas with a higher rate of villitis of unknown etiology (aOR 2.97, 95% CI 1.17-6.66, P = 0.02), distal villous hypoplasia (aOR 3.78, 95% CI 1.20-11.38, P = 0.02), intervillous thrombosis (aOR 2.41, 95% CI 1.39-4.16, P = 0.001), multiple maternal malperfusion lesions (aOR 1.59, 95% CI 1.06-2.37, P = 0.02), and parenchymal calcifications (aOR 2.19, 95% CI 1.07-4.46, P = 0.03). LIMITATIONS, REASONS FOR CAUTION: The study is limited by its retrospective design and the utilization of two grading systems during the study period. In addition, the sample size was limited to detect differences in outcomes of rarer occurrences. WIDER IMPLICATIONS OF THE FINDINGS: The placental lesions demonstrated in our study imply an altered immunological response to the implantation of poor-quality embryos. Yet, these findings were not associated with additional adverse obstetric outcomes and merit reaffirmation in a larger cohort. Overall, the clinical findings of our study are reassuring to clinicians and patients for whom the transfer of a poor-quality embryo is necessary. STUDY FUNDING/COMPETING INTEREST(S): No external funding was obtained for this study. The authors declare no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Ganer Herman H, Volodarsky-Perel A, Ton Nu TN, et al. Does embryo quality at transfer affect obstetric outcomes and placental findings? Hum Reprod. 2023. PMID: 36892579. doi:10.1093/humrep/dead045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。